Add to ORKGPkd1-KO, but not in controls. Conclusion: These findings suggest that pioglitazone may have a unique antihyperten-sive effect in polycystic kidney disease, and that such an ef-fect may promote improved survival. Copyright © 2009 S. Karger AG, Base
poster abstractApproximately 1 in 500 middle aged people in the United States will be diagnosed with...
Polycystic kidney disease (PKD) is a progressive genetic disorder ultimately leading to renal failur...
Copyright © 2013 Munire Kuru Karabas et al. This is an open access article distributed under the Cre...
poster abstractPolycystic kidney disease is a genetic disorder characterized by growth of fluid-fill...
Background/Aims: Pioglitazone is a type of peroxisome proliferator-activated receptor γ agonist...
Polycystic kidney disease (PKD) is a genetic disorder characterized by growth of fluid-filled cysts ...
Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitu
Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabet...
Copyright © 2012 Daisuke Yoshihara et al. This is an open access article distributed under the Creat...
Background: Multiple preclinical studies have highlighted AMP-activated protein kinase (AMPK) as a p...
<p>WT mice were injected with a lethal dose of 1×10<sup>5</sup> cfus Ca and treated daily with 5 mg/...
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the most common monogenic disorders, ...
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor.BackgroundWe have prev...
Background: Acute kidney injury is the most life-threatening complication of rhabdomyolysis. Glycero...
BACKGROUND: Multiple preclinical studies have highlighted AMP-activated protein kinase (AMPK) as a p...
poster abstractApproximately 1 in 500 middle aged people in the United States will be diagnosed with...
Polycystic kidney disease (PKD) is a progressive genetic disorder ultimately leading to renal failur...
Copyright © 2013 Munire Kuru Karabas et al. This is an open access article distributed under the Cre...
poster abstractPolycystic kidney disease is a genetic disorder characterized by growth of fluid-fill...
Background/Aims: Pioglitazone is a type of peroxisome proliferator-activated receptor γ agonist...
Polycystic kidney disease (PKD) is a genetic disorder characterized by growth of fluid-filled cysts ...
Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitu
Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabet...
Copyright © 2012 Daisuke Yoshihara et al. This is an open access article distributed under the Creat...
Background: Multiple preclinical studies have highlighted AMP-activated protein kinase (AMPK) as a p...
<p>WT mice were injected with a lethal dose of 1×10<sup>5</sup> cfus Ca and treated daily with 5 mg/...
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the most common monogenic disorders, ...
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor.BackgroundWe have prev...
Background: Acute kidney injury is the most life-threatening complication of rhabdomyolysis. Glycero...
BACKGROUND: Multiple preclinical studies have highlighted AMP-activated protein kinase (AMPK) as a p...
poster abstractApproximately 1 in 500 middle aged people in the United States will be diagnosed with...
Polycystic kidney disease (PKD) is a progressive genetic disorder ultimately leading to renal failur...
Copyright © 2013 Munire Kuru Karabas et al. This is an open access article distributed under the Cre...